Portal de Periódicos da CAPES

PREVALENCE AND INDEPENDENT RISK FACTORS FOR ERECTILE DYSFUNCTION IN SPAIN: RESULTS OF THE EPIDEMIOLOGIA DE LA DISFUNCION ERECTIL MASCULINA STUDY

2001; Lippincott Williams & Wilkins; Volume: 166; Issue: 2 Linguagem: Inglês

10.1016/s0022-5347(05)65986-1

1527-3792

Antonio Martín‐Morales, José Juan Sánchez-Cruz, Iñigo Sáenz de Tejada, L. Rodríguez-Vela, J.F. Jiménez-Cruz, R. Burgos-Rodriguez,

Sexuality, Behavior, and Technology

No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Aug 2001PREVALENCE AND INDEPENDENT RISK FACTORS FOR ERECTILE DYSFUNCTION IN SPAIN: RESULTS OF THE EPIDEMIOLOGIA DE LA DISFUNCION ERECTIL MASCULINA STUDY ANTONIO MARTIN-MORALES, JOSE J. SANCHEZ-CRUZ, IÑIGO SAENZ DE TEJADA, LUIS RODRIGUEZ-VELA, J. FERNANDO JIMENEZ-CRUZ, and RAFAEL BURGOS-RODRIGUEZ ANTONIO MARTIN-MORALESANTONIO MARTIN-MORALES , JOSE J. SANCHEZ-CRUZJOSE J. SANCHEZ-CRUZ , IÑIGO SAENZ DE TEJADAIÑIGO SAENZ DE TEJADA , LUIS RODRIGUEZ-VELALUIS RODRIGUEZ-VELA , J. FERNANDO JIMENEZ-CRUZJ. FERNANDO JIMENEZ-CRUZ , and RAFAEL BURGOS-RODRIGUEZRAFAEL BURGOS-RODRIGUEZ View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)65986-1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We determined the prevalence of and risks factors for erectile dysfunction in Spain in a cross-sectional study. Materials and Methods: A total of 2,476 noninstitutionalized Spanish men 25 to 70 years old were interviewed at home and answered a self-administered questionnaire of 71 items, including 2 instruments to define erectile dysfunction, a simple self-assessment question to estimate erectile function and the International Index of Erectile Function. Data on disease, medication and toxic habits were also obtained. Results: With an overall participation rate of 75% the prevalence of erectile dysfunction according to the simple question was 12.1%. According to the erectile function domain of the International Index of Erectile Function the overall prevalence was 18.9%. Several independent risk factors were significantly associated with the probability of erectile dysfunction. Some differences arose according to the tool used to define the condition. However, there was a strong relationship of patient age with frequency or severity no matter which instrument was used to define erectile dysfunction. Diabetes (age adjusted odds ratio 4), high blood pressure (odds ratio 1.58), high cholesterol (1.63), peripheral vascular disorder (2.63), lung disease (3.11), prostate disease (2.93), cardiac problems (1.79), rheumatism (2.37) and allergy (3.08) were significantly associated with erectile dysfunction. Drug intake, which respondents called medication for nerves and sleeping pills, correlated strongly (odds ratio 2.78 and 4.27, respectively), as did tobacco use (2.5) and alcohol consumption (1.53). Conclusions: This study provides data on the prevalence of and risks factors for erectile dysfunction in Spain. The relationship of erectile dysfunction with certain risk factors, such as cardiovascular risk factors and drugs intake, are well known and our study corroborates these associations. Other associations with erectile dysfunction, such as prostate disease, allergy and rheumatism, support findings in previous reports, although to our knowledge the pathophysiological mechanisms remain unclear. Estimating the strength of the association of erectile dysfunction with distinct risk factors in terms of odds ratios enabled us to identify the factors to pursue when seeking to prevent erectile dysfunction. Furthermore, the relationship of tobacco with erectile dysfunction, which has been controversial in previous series, was well characterized in our study. References 1 NIH Consensus Conference: Impotence: NIH Development Panel on Impotence. JAMA1993; 270: 83. Google Scholar 2 : The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int1999; 84: 50. Google Scholar 3 : The epidemiology of erectile dysfunction. Urol Clin North Am1995; 22: 699. Google Scholar 4 Manual de Puntuación de la Versión Española del Cuestionario de Salud SF-36. Barcelona. Spain: Unitat de Recerca en Serveis Sanitaris, Institut Municipal d'Investigació Mèdica1998. Google Scholar 5 : SF-36 Health Survey manual and interpretation guide. Boston: New England Medical Center, The Health Institute1993. Google Scholar 6 : Detecting alcoholism. The CAGE questionnaire. JAMA1984; 252: 1905. Google Scholar 7 : Validation of the International Prostate Symptom Score in Spain. The 2nd International Consultation on Benign Prostatic Hyperplasia: Proceedings. In: . Edited by . Jersey, Channel Islands: Scientific Communication International1993: 129. Google Scholar 8 : The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology1997; 49: 822. Crossref, Medline, Google Scholar 9 Glasser, D. and Sweeney, M.: The prevalence of erectile dysfunction in four countries: Italy, Brazil, Malaysia and Japan. Cross-National Study Group. Presented at International Consultation on Erectile Dysfunction, Paris, France, July 1–3, 1999 Google Scholar 10 : Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol1994; 151: 54. Link, Google Scholar 11 Hussain, S. S., Siddiqui, S., Razzaq, M. A. et al: A patient based epidemiology study to find the prevalence and correlates of erectile dysfunction (ED) in two cities in Pakistan. Presented at European Society for Impotence Research Meeting, Barcelona, Spain, January 30 to February 2, 2000 Google Scholar 12 Akkus, E., Kadioglu, A., Esen, A. et al: Prevalence of erectile dysfunction among urban and rural population in Turkey. Presented at ESIR Meeting, Barcelona, Spain, XXX, 2000 Google Scholar 13 Mahmoud, K. Z., Azim, S. A., Gadallah, M. et al: A patient based epidemiology study to find the prevalence and correlates of erectile dysfunction (ED) in Egypt. Presented at ESIR Meeting, Barcelona, Spain, XXX, 2000 Google Scholar 14 Kadiri, N., Berrada, S., Tahiri, S. et al: Prevalence of erectile dysfunction (ED) and its correlates in Morocco: a population based epidemiological study. Presented at ESIR Meeting, Barcelona, Spain, XXX, 2000 Google Scholar 15 Dogunro, S., Osegbe, D. and Jaguste, V. S.: Epidemiology of erectile dysfunction (ED) and its correlates: a patient based study in Nigerian population. Presented at ESIR Meeting, Barcelona, Spain, XXX, 2000 Google Scholar 16 Koskimaki, K., Hakama, M. and Tammela, T. L. J.: Prevalence of erectile dysfunction in Finland. Presented at ESIR Meeting, Barcelona, Spain, XXX, 2000 Google Scholar 17 La Pera, G., Taggi, F., Aloise, L. et al: Prevalence of the erectile dysfunction and of other genitourinary symptoms: preliminary results of the SIMONA study group. Presented at ESIR Meeting, Barcelona, Spain, XXX, 2000 Google Scholar 18 : Frequency and determinants of erectile dysfunction in Italy. Eur Urol2000; 37: 43. Google Scholar 19 : Sexual dysfunction in the United States. Prevalence and predictors. JAMA1999; 281: 537. Google Scholar 20 : Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology1999; 54: 346. Crossref, Medline, Google Scholar 21 : Relationship between patient self-assessment of erectile function and the erectile function domain of the International Index of Erectile Function. Urology2000; 56: 477. Google Scholar 22 : Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study. Int J Impot Res2000; 12: 197. Crossref, Medline, Google Scholar 23 : Multifactorial evaluation of diabetic erectile dysfunction. Int Urol Nephrol1996; 28: 717. Google Scholar 24 Vibe-Petersen, J., Behrend, L., Jorgensen, T. et al: The prevalence of erectile dysfunction in a male diabetic population. Presented at ESIR Meeting, Barcelona, Spain, XXX, 2000 Google Scholar 25 : Drug-induced male sexual dysfunction. Urol Clin North Am1988; 15: 23. Google Scholar 26 : Erectile dysfunction: is medication to blame?. Prescriber1997; 3: 77. Google Scholar 27 : Cigarette smoking: an independent risk factor for impotence?. Am J Epidemiol1994; 140: 1003. Google Scholar 28 : Prevalence and significance of tobacco smoking in impotence. Urology1986; 27: 495. Google Scholar 29 : Chronic alcoholism and male sexual dysfunction. J Sex Marital Ther1990; 16: 23. Google Scholar From the Urology Department, Carlos Haya Hospital, Malaga, Andalusian School of Public Health, Granada and Fundacion para la Investigacion y Desarrollo en Andrologia and Spanish Urological Association, Madrid, Spain© 2001 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byWessells H, Joyce G, Wise M and Wilt T (2018) Erectile DysfunctionJournal of Urology, VOL. 177, NO. 5, (1675-1681), Online publication date: 1-May-2007.Shiri R, Koskimäki J, Tammela T, Häkkinen J, Auvinen A and Hakama M (2018) Bidirectional Relationship Between Depression and Erectile DysfunctionJournal of Urology, VOL. 177, NO. 2, (669-673), Online publication date: 1-Feb-2007.Bacon C, Mittleman M, Kawachi I, Giovannucci E, Glasser D and Rimm E (2018) A Prospective Study of Risk Factors for Erectile DysfunctionJournal of Urology, VOL. 176, NO. 1, (217-221), Online publication date: 1-Jul-2006.Shiri R, Koskimäki J, Häkkinen J, Tammela T, Auvinen A and Hakama M (2018) Effect of Nonsteroidal Anti-Inflammatory Drug Use on the Incidence of Erectile DysfunctionJournal of Urology, VOL. 175, NO. 5, (1812-1816), Online publication date: 1-May-2006.Burnett A (2018) Erectile DysfunctionJournal of Urology, VOL. 175, NO. 3S, (S25-S31), Online publication date: 1-Mar-2006.KÖSEOĞLU N, KÖSEOĞLU H, CEYLAN E, ÇIMRIN H, ÖZALEVLI S and ESEN A (2018) ERECTILE DYSFUNCTION PREVALENCE AND SEXUAL FUNCTION STATUS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASEJournal of Urology, VOL. 174, NO. 1, (249-252), Online publication date: 1-Jul-2005.USTA M, BIVALACQUA T, JABREN G, MYERS L, SANABRIA J, SIKKA S and HELLSTROM W (2018) Relationship Between the Severity of Penile Curvature and the Presence of Comorbidities in Men With Peyronie's DiseaseJournal of Urology, VOL. 171, NO. 2, (775-779), Online publication date: 1-Feb-2004.MARTÍNEZ R, PUIGVERT A, POMEROL J and RODRÍGUEZ-VILLALBA R (2018) Clinical Experience With Apomorphine Hydrochloride: The First 107 PatientsJournal of Urology, VOL. 170, NO. 6, (2352-2355), Online publication date: 1-Dec-2003.SHIRI R, KOSKIMÄKI J, HAKAMA M, HÄKKINEN J, TAMMELA T, HUHTALA H and AUVINEN A (2018) Prevalence and Severity of Erectile Dysfunction in 50 to 75-Year-Old Finnish MenJournal of Urology, VOL. 170, NO. 6, (2342-2344), Online publication date: 1-Dec-2003.COSTABILE R (2018) Optimizing Treatment for Diabetes Mellitus Induced Erectile DysfunctionJournal of Urology, VOL. 170, NO. 2S, (S35-S39), Online publication date: 1-Aug-2003.SIROKY M and AZADZOI K (2018) Vasculogenic Erectile Dysfunction: Newer Therapeutic StrategiesJournal of Urology, VOL. 170, NO. 2S, (S24-S30), Online publication date: 1-Aug-2003.SEFTEL A (2018) Erectile Dysfunction in the Elderly: Epidemiology, Etiology and Approaches to TreatmentJournal of Urology, VOL. 169, NO. 6, (1999-2007), Online publication date: 1-Jun-2003. Volume 166Issue 2August 2001Page: 569-575 Advertisement Copyright & Permissions© 2001 by American Urological Association, Inc.Keywordsimpotenceepidemiologyquestionnairesrisk factorsMetricsAuthor Information ANTONIO MARTIN-MORALES Financial interest and/or other relationship with Pfizer, Fundacion para la Investigacion y Desarrollo en Andrologia and UROAN XXI. More articles by this author JOSE J. SANCHEZ-CRUZ Financial interest and/or other relationship with Pfizer, Fundacion para la Investigacion y Desarrollo en Andrologia and UROAN XXI. More articles by this author IÑIGO SAENZ DE TEJADA Financial interest and/or other relationship with Pfizer, Fundacion para la Investigacion y Desarrollo en Andrologia and UROAN XXI. More articles by this author LUIS RODRIGUEZ-VELA Financial interest and/or other relationship with Pfizer, Fundacion para la Investigacion y Desarrollo en Andrologia and UROAN XXI. More articles by this author J. FERNANDO JIMENEZ-CRUZ Financial interest and/or other relationship with Pfizer, Fundacion para la Investigacion y Desarrollo en Andrologia and UROAN XXI. More articles by this author RAFAEL BURGOS-RODRIGUEZ Financial interest and/or other relationship with Pfizer, Fundacion para la Investigacion y Desarrollo en Andrologia and UROAN XXI. More articles by this author Expand All Advertisement PDF downloadLoading ...